Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Multiple drugs

Various toxicities: 7 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Taga S, et al. [Incidence of Immune-Related Adverse Events after Switching from a Conventional Regimen of Nivolumab and Pembrolizumab to the Extended Dosing Interval Regimen]. [Japanese]. Gan to Kagaku Ryoho 49: 1093-1097, No. 10, Oct 2022 [Japanese; summarised from a translation] Taga S, et al. [Incidence of Immune-Related Adverse Events after Switching from a Conventional Regimen of Nivolumab and Pembrolizumab to the Extended Dosing Interval Regimen]. [Japanese]. Gan to Kagaku Ryoho 49: 1093-1097, No. 10, Oct 2022 [Japanese; summarised from a translation]
Metadaten
Titel
Multiple drugs
Various toxicities: 7 case reports
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41569-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Fostamatinib

Case report

Methadone

Case report

Multiple drugs